15 Jul 2013 Posted in ABPI statement By Press Office
"The increase in the number of animals used and in the procedures carried out should be seen in the context that such research has contributed to many of the medical advances we now take for granted. We have all benefited from vaccines and antibiotics developed to prevent and treat infections, and anaesthetics used in all forms of surgery.
"Medicines can now overcome serious conditions such as diabetes, asthma, and high blood pressure. Research in the last few decades has also begun to tackle some of the more difficult medical problems such as heart disease, dementia, depression, many cancers and newly emerged infections such as HIV. Only further research will address these diseases and these studies offer hope to millions of people who suffer from them."
ABPI Press Office
Tel: +44 (0) 20 7747 1410 or +44 (0) 20 7747 1441
Mobile: +44 (0) 7850 312064 or +44 (0) 7808 641811
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by Government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.